Loading clinical trials...

Fundus-First Laparoscopic Cholecystectomy in Difficult Gallbladders: A Safe Alternative Technique | Clinical Trials | Clareo Health

COMPLETED

Fundus-First Laparoscopic Cholecystectomy in Difficult Gallbladders: A Safe Alternative Technique

Fundus-First Laparoscopic Cholecystectomy in Difficult Gallbladders: A Retrospective Cross-Sectional Study on a Safe Alternative to Avoid Conversion

NCT07113704•KANAN ISMAYILZADA, MD

View on ClinicalTrials.gov

Summary

This retrospective cross-sectional study evaluated the safety and effectiveness of the fundus-first laparoscopic cholecystectomy (FFLC) technique in patients with difficult gallbladders. A total of 124 patients who underwent FFLC between 2023 and 2024 were reviewed. The study assessed operative time, intraoperative complications, conversion rates, and postoperative outcomes. The results suggest that FFLC is a safe and feasible approach that can reduce the need for conversion to open surgery in complex cases. The study was conducted at a private hospital in Istanbul, Turkey

Detailed Description

This retrospective study was conducted at a private healthcare institution without a formal IRB. All patient data were anonymised before analysis, and written informed consent was obtained from all patients for the academic use of their clinical data

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients who underwent laparoscopic cholecystectomy at the study center between January 2023 and March 2024
•Patients diagnosed with difficult gallbladder (Nassar Grade 3-4)
•Age ≥ 18 years
•Complete clinical data available for analysis

Exclusion Criteria

•Patients with incomplete medical records
•Patients undergoing open cholecystectomy from the beginning
•Patients under 18 years of age

Locations (1)

Medicana Ataşehir International Hospital

Istanbul, Ataşehir, Turkey (Türkiye)

Key Dates

Start Date

January 5, 2023

Primary Completion Date

April 1, 2024

Completion Date

April 10, 2024

Last Updated

August 11, 2025

Enrollment

124

ACTUAL participants

Conditions

Cholelithiasis

Interventions

Conventional Laparoscopic Cholecystectomy

PROCEDURE

Fundus-First Laparoscopic Cholecystectomy

PROCEDURE

A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

NCT07005752

Cholesterol Cholelithiasis

View study

RECRUITINGNA

STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy

NCT06123117

CholelithiasisCholecystitis+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 11, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Fundus-First Laparoscopic Cholecystectomy in Difficult Gallbladders: A Safe Alternative Technique

Inclusion Criteria

Exclusion Criteria

A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy

Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study

Effect of Erector Spinae Plane Block on Postoperative Respiratory Function After Laparoscopic Cholecystectomy

Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Early Versus Interval Laparoscopic Cholecystectomy for Acute Cholecystitis